Methylnonafluorovalerate

Catalog No. :
ACPKHF746
CAS No. :
13038-26-1
Molecular Formula :
C6H3F9O2
Molecular Weight :
278.07

IUPAC Name:methyl 2,2,3,3,4,4,5,5,5-nonafluoropentanoate

Methylnonafluorovalerate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$56.00Login to see priceIn stockInquiry
5g95%$175.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethylnonafluorovalerate
IUPAC Namemethyl 2,2,3,3,4,4,5,5,5-nonafluoropentanoate
MDL No.MFCD00443384
Molecular FormulaC6H3F9O2
Molecular Weight278.07
SMILESCOC(=O)C(F)(F)C(F)(F)C(F)(F)C(F)(F)F
InChI KeyOSDPSOBLGQUCQX-UHFFFAOYSA-N
Synonym6-Methoxy-N-[(E)-(4-methylphenyl)methylidene]-1,3-benzothiazol-2-amine | Methyl Perfluorovalerate | Pentanoic acid, 2,2,3,3,4,4,5,5,5-nonafluoro-, methyl ester | Methyl Nonafluoropentanoate | SCHEMBL2690305 | D91550 | AS-77292 | 5,6,7,8-Tetrahydro-2-napht
CAS No.13038-26-1
PubChem CID526458

Safety Data

Pictogram
FlammableHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H225-H315-H319
Precautionary Statement(s)
P210-P233-P240-P241-P242-P243-P264-P280-P303+P361+P353-P305+P351+P338-P332+P313-P337+P313-P362-P370+P378-P403+P235-P501

Synthetic Route by SureRoute

1. ACPKHF746 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACMPWJ514 route compound structure diagram
    --
  4. Then
  5. ACPKHF746 route product structure diagram
    ACPKHF74613038-26-1 In Stock
Inquiry

2. ACPKHF746 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPKHF746 route product structure diagram
    ACPKHF74613038-26-1 In Stock
Inquiry

Comments (0)